Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients

Melissa Kerkhof; Pauline L. Tans; Rogier E. Hagenbeek; Geert J. Lycklama À Nijeholt; Finn K. Holla; Tjeerd J. Postma; Chiara S. Straathof; Linda Dirven; Martin Jb Taphoorn; Maaike J. Vos

doi:10.2217/cns-2017-0013

Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients

Melissa Kerkhof
, Pauline L. Tans
, Rogier E. Hagenbeek
, Geert J. Lycklama À Nijeholt
, Finn K. Holla
, Tjeerd J. Postma
, Chiara S. Straathof
, Linda Dirven
, Martin Jb Taphoorn
, Maaike J. Vos

Department of Neurology, 2501 CK The Hague, Netherlands
Department of Radiology, 2501 CK The Hague, Netherlands
Leiden University

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

AIM: We examined whether visual interpretation of relative cerebral blood volume (rCBV) color maps made with dynamic susceptibility-weighted perfusion MRI can reliably distinguish progressive disease (PD) from pseudoprogression (PsPD) in glioblastoma patients during treatment with temozolomide chemoradiation.

Original language	English
Pages (from-to)	297-306
Journal	CNS oncology
Volume	6
Issue number	4
DOIs	https://doi.org/10.2217/cns-2017-0013
Publication status	Published - 2017

Access to Document

10.2217/cns-2017-0013

Cite this

Kerkhof, M., Tans, P. L., Hagenbeek, R. E., Lycklama À Nijeholt, G. J., Holla, F. K., Postma, T. J., Straathof, C. S., Dirven, L., Taphoorn, M. J., & Vos, M. J. (2017). Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients. CNS oncology, 6(4), 297-306. https://doi.org/10.2217/cns-2017-0013

@article{158a42712f63497ab293cc2dcf5c9d19,

title = "Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients",

abstract = "AIM: We examined whether visual interpretation of relative cerebral blood volume (rCBV) color maps made with dynamic susceptibility-weighted perfusion MRI can reliably distinguish progressive disease (PD) from pseudoprogression (PsPD) in glioblastoma patients during treatment with temozolomide chemoradiation.",

author = "Melissa Kerkhof and Tans, \{Pauline L.\} and Hagenbeek, \{Rogier E.\} and \{Lycklama {\`A} Nijeholt\}, \{Geert J.\} and Holla, \{Finn K.\} and Postma, \{Tjeerd J.\} and Straathof, \{Chiara S.\} and Linda Dirven and Taphoorn, \{Martin Jb\} and Vos, \{Maaike J.\}",

year = "2017",

doi = "10.2217/cns-2017-0013",

language = "English",

volume = "6",

pages = "297--306",

journal = "CNS oncology",

issn = "2045-0915",

publisher = "Future Medicine Ltd.",

number = "4",

}

Kerkhof, M, Tans, PL, Hagenbeek, RE, Lycklama À Nijeholt, GJ, Holla, FK, Postma, TJ, Straathof, CS, Dirven, L, Taphoorn, MJ & Vos, MJ 2017, 'Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients', CNS oncology, vol. 6, no. 4, pp. 297-306. https://doi.org/10.2217/cns-2017-0013

TY - JOUR

T1 - Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients

AU - Kerkhof, Melissa

AU - Tans, Pauline L.

AU - Hagenbeek, Rogier E.

AU - Lycklama À Nijeholt, Geert J.

AU - Holla, Finn K.

AU - Postma, Tjeerd J.

AU - Straathof, Chiara S.

AU - Dirven, Linda

AU - Taphoorn, Martin Jb

AU - Vos, Maaike J.

PY - 2017

Y1 - 2017

N2 - AIM: We examined whether visual interpretation of relative cerebral blood volume (rCBV) color maps made with dynamic susceptibility-weighted perfusion MRI can reliably distinguish progressive disease (PD) from pseudoprogression (PsPD) in glioblastoma patients during treatment with temozolomide chemoradiation.

AB - AIM: We examined whether visual interpretation of relative cerebral blood volume (rCBV) color maps made with dynamic susceptibility-weighted perfusion MRI can reliably distinguish progressive disease (PD) from pseudoprogression (PsPD) in glioblastoma patients during treatment with temozolomide chemoradiation.

UR - https://www.scopus.com/pages/publications/85050618755

UR - https://www.ncbi.nlm.nih.gov/pubmed/28984142

U2 - 10.2217/cns-2017-0013

DO - 10.2217/cns-2017-0013

M3 - Article

C2 - 28984142

SN - 2045-0915

VL - 6

SP - 297

EP - 306

JO - CNS oncology

JF - CNS oncology

IS - 4

ER -

Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients

Abstract

Access to Document

Other files and links

Fingerprint

Cite this